2017 Q4 Form 10-K Financial Statement

#000143774918005759 Filed on March 29, 2018

View on sec.gov

Income Statement

Concept 2017 Q4 2017
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income
YoY Change
Income Tax $0.00
% Of Pretax Income
Net Earnings
YoY Change
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2017 Q4 2017
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.300M $5.300M
YoY Change 39.47% 39.47%
Cash & Equivalents $5.300M $5.300M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables $0.00 $0.00
Other Receivables $100.0K $100.0K
Total Short-Term Assets $5.400M $5.400M
YoY Change 38.46% 38.46%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $33.00M $33.00M
YoY Change 6.45% 6.45%
Total Long-Term Assets $33.00M $33.00M
YoY Change -5.98% -5.98%
TOTAL ASSETS
Total Short-Term Assets $5.400M $5.400M
Total Long-Term Assets $33.00M $33.00M
Total Assets $38.40M $38.40M
YoY Change -1.54% -1.54%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $500.0K $500.0K
YoY Change 25.0% 25.0%
Accrued Expenses $300.0K $300.0K
YoY Change 50.0% 50.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.100M $1.100M
YoY Change 22.22% 22.22%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $10.70M $10.70M
YoY Change 8.08% 8.08%
Total Long-Term Liabilities $10.70M $10.70M
YoY Change 8.08% 8.08%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.100M $1.100M
Total Long-Term Liabilities $10.70M $10.70M
Total Liabilities $11.80M $11.80M
YoY Change 8.26% 8.26%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $26.60M $26.60M
YoY Change
Total Liabilities & Shareholders Equity $38.40M $38.40M
YoY Change -1.54% -1.54%

Cashflow Statement

Concept 2017 Q4 2017
OPERATING ACTIVITIES
Net Income
YoY Change
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q2 gyro Additional Bonus Pool Funding Additional Percentage Of Gross Sales Price On Property Appreciation
AdditionalBonusPoolFundingAdditionalPercentageOfGrossSalesPriceOnPropertyAppreciation
0.02
CY2014Q2 gyro Additional Bonus Pool Funding Percentage Of Gross Sales Price On First Ten Percent Of Property Appreciation
AdditionalBonusPoolFundingPercentageOfGrossSalesPriceOnFirstTenPercentOfPropertyAppreciation
0.1
CY2014Q2 gyro Additional Bonus Pool Funding Percentage Of Gross Sales Price On Property Appreciation Greater Than Twenty Percent
AdditionalBonusPoolFundingPercentageOfGrossSalesPriceOnPropertyAppreciationGreaterThanTwentyPercent
0.2
CY2014Q2 gyro Additional Bonus Pool Funding Percentage Of Gross Sales Price On Second Ten Percent Of Property Appreciation
AdditionalBonusPoolFundingPercentageOfGrossSalesPriceOnSecondTenPercentOfPropertyAppreciation
0.15
CY2014Q2 gyro Bonus Pool Funding As Percentage Of Appraised Value Of Contributed Properties
BonusPoolFundingAsPercentageOfAppraisedValueOfContributedProperties
0.05
CY2017Q3 gyro Liquidation Basis Of Accounting Special Distribution Amount Paid
LiquidationBasisOfAccountingSpecialDistributionAmountPaid
1482680
CY2017Q3 gyro Liquidation Basis Of Accounting Special Distribution In Common Share Paid Per Share
LiquidationBasisOfAccountingSpecialDistributionInCommonSharePaidPerShare
1
CY2016 gyro Marketable Securities Adjusted Duration
MarketableSecuritiesAdjustedDuration
P4Y
CY2016 gyro Marketable Securities Estimated Yield
MarketableSecuritiesEstimatedYield
0.02
CY2016 gyro Number Of Major Customers
NumberOfMajorCustomers
3
CY2017 gyro Number Of Major Customers
NumberOfMajorCustomers
3
CY2017Q1 gyro Percentage Of Mortgage Backed Securities Sold
PercentageOfMortgageBackedSecuritiesSold
1
CY2017 gyro Real Estate Heldforsale Period Increase Decrease
RealEstateHeldforsalePeriodIncreaseDecrease
4791665
CY2016 gyro Real Estate Heldforsale Period Increase Decrease
RealEstateHeldforsalePeriodIncreaseDecrease
2336000
CY2014Q2 gyro Retention Bonus Plan Gross Selling Price Requirement Percentage
RetentionBonusPlanGrossSellingPriceRequirementPercentage
1
CY2016Q2 gyro Total Compensation Expense And Directors Fees
TotalCompensationExpenseAndDirectorsFees
233200
CY2017Q4 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
261160
CY2016Q4 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
224617
CY2017Q4 us-gaap Accrued Payroll Taxes Current And Noncurrent
AccruedPayrollTaxesCurrentAndNoncurrent
23780
CY2016Q4 us-gaap Accrued Payroll Taxes Current And Noncurrent
AccruedPayrollTaxesCurrentAndNoncurrent
29930
CY2017Q4 us-gaap Accrued Professional Fees Current And Noncurrent
AccruedProfessionalFeesCurrentAndNoncurrent
102703
CY2016Q4 us-gaap Accrued Professional Fees Current And Noncurrent
AccruedProfessionalFeesCurrentAndNoncurrent
153992
CY2016Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
101442
CY2016Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
44000
CY2015Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
49000
CY2017Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
34000
CY2017 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
10000
CY2016 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
5000
CY2017Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
CY2016Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
4087231
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1482680
CY2017 us-gaap Deferred Compensation Arrangement With Individual Distribution Paid
DeferredCompensationArrangementWithIndividualDistributionPaid
304052
CY2016 us-gaap Deferred Compensation Arrangement With Individual Distribution Paid
DeferredCompensationArrangementWithIndividualDistributionPaid
1254248
CY2017Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2017 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
730.85
CY2017 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2017 us-gaap Loss Contingency Disclosures
LossContingencyDisclosures
<div style="display: inline; font-family: times new roman; font-size: 10pt"><table style=";font-family:'Times New Roman', Times, serif;font-size:10pt; min-width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="width:18pt;vertical-align:top;"> <div style=" font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:left;margin-bottom:0pt;font-size:10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20.</div></div></div> </td> <td style="vertical-align:top;"> <div style=" font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:left;margin-bottom:0pt;font-size:10pt;"><div style="display: inline; font-weight: bold;">Contingencies</div></div> </td> </tr> </table> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:18pt;margin-top:0pt;text-align:justify;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-left: 18pt; margin-top: 0pt; text-align: justify;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Putative Class Action Lawsuit -</div></div><div style="display: inline; font-family:'Times New Roman', Times, serif;font-size:10pt;"> On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 3, 2014, </div>a purported stockholder of the Company filed a putative class action lawsuit against Gyrodyne Company of America, Inc. (the &#x201c;Corporation&#x201d;) and members of its Board of Directors (the &quot;Individual Defendants&quot;), and against GSD and the Company (collectively, the &quot;Defendants&quot;), in the Supreme Court of the State of New York, County of Suffolk (the &quot;Court&quot;), captioned Cashstream Fund v. Paul L. Lamb, et al., Index <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">065134/2014</div> (the &quot;Action&quot;). The complaint alleged, among other things, that (i) the Individual Defendants breached their fiduciary duties or aided and abetted the breach of those duties in connection with the merger of the Corporation and GSD into the Company (the &#x201c;Merger&#x201d;) and (ii) the Corporation and the Individual Defendants breached their fiduciary duties by failing to disclose material information in the proxy statement/prospectus relating to the Merger.</div></div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-left: 18pt; margin-top: 0pt; text-align: justify;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-left: 18pt; margin-top: 0pt; text-align: justify;">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August 14, 2015, </div>the parties to the Action entered into a Stipulation of Settlement (the &quot;Settlement&quot;) providing for the settlement of the Action, subject to the Court's approval. Under the Settlement, Gyrodyne amended its Proxy Statement on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August 17, 2015 </div>with certain supplemental disclosures and agreed that any sales of its properties would be effected only in arm's-length transactions at prices at or above their appraised values as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 2014. </div>The plaintiff, on behalf of itself and the members of the putative class it represents, agreed to release and dismiss with prejudice all claims that had or could have been asserted in the Action or in any other forum against the Defendants and their affiliates and agents arising out of or relating to the Merger and the other transactions alleged by plaintiff in its complaint, as supplemented. On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> April 8, 2016, </div>the Court entered a Final Order and Judgment approving the Settlement. By order of the same date, the Court also granted plaintiff<div style="display: inline; font-family:'Times New Roman', Times, serif;font-size:10pt;">&#x2019;s application for an award of attorney&#x2019;s fees and reimbursement of expenses in the amount of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$650,000</div> which was paid in full in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> April 2016.</div></div></div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-left: 18pt; margin-top: 0pt; text-align: justify;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-left: 18pt; margin-top: 0pt; text-align: justify;">The <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div> aggregate appraised value of Gyrodyne<div style="display: inline; font-family:'Times New Roman', Times, serif;font-size:10pt;">&#x2019;s properties was approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$100,000</div> higher than the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2013</div> aggregate appraised value for such properties. As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017, </div>the aggregate value of the remaining unsold properties was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$4,416,665</div> higher than the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div> appraised value.</div></div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-left: 18pt; margin-top: 0pt; text-align: justify;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-left: 18pt; margin-top: 0pt; text-align: justify;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">General -</div></div><div style="display: inline; font-family:'Times New Roman', Times, serif;font-size:10pt;"> In the normal course of business, the Company is a party to various legal proceedings. After reviewing all actions and proceedings pending against or involving the Company, management considers that any loss resulting from such proceedings individually or in the aggregate will <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> be material to the Company&#x2019;s financial statements.</div></div></div>
CY2016Q2 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
131758
CY2017 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2017Q4 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
134677
CY2016Q4 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
40695
CY2017Q4 us-gaap Other Commitment
OtherCommitment
431716
CY2016Q4 us-gaap Other Commitment
OtherCommitment
677100
CY2017 us-gaap Proceeds From Maturities Prepayments And Calls Of Mortgage Backed Securities Mbs
ProceedsFromMaturitiesPrepaymentsAndCallsOfMortgageBackedSecuritiesMBS
129587
CY2016 us-gaap Proceeds From Maturities Prepayments And Calls Of Mortgage Backed Securities Mbs
ProceedsFromMaturitiesPrepaymentsAndCallsOfMortgageBackedSecuritiesMBS
881066
CY2016Q4 us-gaap Real Estate Heldforsale
RealEstateHeldforsale
31025000
CY2015Q4 us-gaap Real Estate Heldforsale
RealEstateHeldforsale
46950000
CY2017Q4 us-gaap Real Estate Heldforsale
RealEstateHeldforsale
33016665
CY2017 us-gaap Reclassifications
Reclassifications
<div style="display: inline; font-family: times new roman; font-size: 10pt"><table style=";font-family:'Times New Roman', Times, serif;font-size:10pt; min-width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="width:18pt;vertical-align:top;"> <div style=" font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:left;margin-bottom:0pt;font-size:10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">22.</div></div></div> </td> <td style="vertical-align:top;"> <div style=" font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:left;margin-bottom:0pt;font-size:10pt;"><div style="display: inline; font-weight: bold;">Reclassifications</div></div> </td> </tr> </table> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:18pt;margin-top:0pt;text-align:justify;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-left: 18pt; margin-top: 0pt; text-align: justify;">Certain amounts in the prior period have been reclassified to conform to the classification used in the current period.</div></div>
CY2017 us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-left: 18pt; margin-top: 0pt; text-align: justify;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Management Estimates <div style="display: inline; font-family:'Times New Roman', Times, serif;font-size:10pt;">&#x2013; </div></div></div><div style="display: inline; font-family:'Times New Roman', Times, serif;font-size:10pt;">In preparing the consolidated financial statements in conformity with U.S. Generally Accepted Accounting Principles (&#x201c;GAAP&#x201d;) and the liquidation basis of accounting, management is required to make estimates and assumptions that affect the reported amounts of assets, including net assets in liquidation, and liabilities and disclosure of contingent assets and liabilities as of the date of the consolidated financial statements and the reported amounts of receipts and expenditures for the reporting period. Actual results could differ from those estimates.</div></div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-left: 18pt; margin-top: 0pt; text-align: justify;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-left: 18pt; margin-top: 0pt; text-align: justify;">The most significant estimates are the estimates of&nbsp;the net realizable value of our real estate, the estimated costs/time to pursue entitlements/change of zone and the related timeline to complete the liquidation.</div></div></div></div></div></div>
CY2017Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0

Files In Submission

Name View Source Status
0001437749-18-005759-index-headers.html Edgar Link pending
0001437749-18-005759-index.html Edgar Link pending
0001437749-18-005759.txt Edgar Link pending
0001437749-18-005759-xbrl.zip Edgar Link pending
ex_108330.htm Edgar Link pending
ex_108331.htm Edgar Link pending
ex_108455.htm Edgar Link pending
ex_109248.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gyrllc20171231_10k.htm Edgar Link pending
gyro-20171231.xml Edgar Link completed
gyro-20171231.xsd Edgar Link pending
gyro-20171231_cal.xml Edgar Link unprocessable
gyro-20171231_def.xml Edgar Link unprocessable
gyro-20171231_lab.xml Edgar Link unprocessable
gyro-20171231_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending